---
$id: https://graph.org.ai/products/commodity/51263113
$type: Product
source: UNSPSC
code: "51263113"
title: "Bucumolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bucumolol

**UNSPSC Code**: 51263113
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H23NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8WVJ3501L, chemically known as 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-methyl-2h-1-benzopyran-2-one but generally known as bucumolol, which bears US NIH Compound Identifier 169787. Bucumolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bucumolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05954MIG. The term BUCUMOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). BUCUMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BUCUMOLOL remains the US FDA Preferred Term for this commodity. Bucumolol bears US NLM identifiers UMLS ID C0054199 and NCI Concept Code C72611. SMILES: O(CC(O)CNC(C)(C)C)C1C2OC(=O)CCC2C(CC1)C.

